ATP1B2
Sodium/potassium-transporting ATPase subunit beta-2
As of the edition of 20 October 2026, ATP1B2 (sodium/potassium-transporting ATPase subunit beta-2, UniProt P14415) has 1 drug tested at it and 5 companies on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P14415
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Disease areas
- Heart and blood vessels
- Registered trials of its drugs
- 9
Drugs at this target
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Istaroxime | Active | Phase 3 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 5 |
| Total on the list | 5 |